Since its launch in 2014, The Medicine Maker has covered the development and commercial production of large molecule therapeutics with relentless consistency.
Large molecule drugs are core to the future of modern medicine and the innovation taking place in biologic production/bioprocessing is in a constant state of change. Our editors explore the ideas and innovations shaping the future of this sector.
Read an example of the Bioprocessing newsletter here.
Bioprocessing from The Medicine Maker has a dedicated database for the weekly newsletter and third-party targeting. The database has been nurtured over time to build a loyal readership around our continuous coverage of the sector.
As a business, we actively remove readers who ceases to engage with our communications*, ensuring improved targeting for both our products and your marketing.
*not interacting over a set period of time
Editor: Stephanie Sutton | email@example.com
Publisher: Helen Conyngham | firstname.lastname@example.org
Business Development Manager: Chris Connolly | email@example.com
Business Development Manager North America: Stacy Gaines | firstname.lastname@example.org